Skip to main content
. 2018 Apr 23;3(3):280–287. doi: 10.1016/j.adro.2018.04.004

Table 1.

Demographic and clinical characteristics of patients

EBRT (n = 629) SRS/HF-SRS (n = 173) P-value
Age (median) 56 years 56 years .562
Sex .136
 Male 254 (40.4%) 59 (34.1%)
 Female 375 (59.6%) 114 (65.9%)
Tumor size < .001
 ≤3 cm 93 (14.8%) 44 (25.4%)
 3-5 cm 218 (34.7%) 71 (41.0%)
 >5 cm 318 (50.6%) 58 (33.5%)
Charlson Deyo comorbidity score .880
 0 487 (77.4%) 137 (79.2%)
 1 96 (15.3%) 24 (13.9%)
 ≥2 46 (7.3%) 12 (6.9%)
Race .007
 White 491 (78.1%) 151 (87.3%)
 Nonwhite 138 (21.9%) 22 (12.7%)
WHO grade < .001
 I 199 (31.6%) 117 (67.6%)
 II 430 (68.4%) 56 (32.4%)
Surgery < .001
 STR 356 (56.6%) 150 (86.7%)
 GTR 248 (39.4%) 17 (9.8%)
 Resection, NOS 25 (4.0%) 6 (3.5%)
Facility type .450
 Nonacademic 237 (43.0%) 57 (39.3%)
 Academic 314 (57.0%) 88 (60.7%)
Region .002
 Northeast 121 (22.0%) 33 (22.8%)
 Midwest 146 (26.5%) 22 (15.2%)
 South 169 (30.7%) 41 (28.3%)
 West 115 (20.9%) 49 (33.8%)
Insurance .087
 Not insured 47 (7.5%) 5 (2.9%)
 Private insurance 345 (54.8%) 109 (63.0%)
 Medicaid 59 (9.4%) 10 (5.8%)
 Medicare 153 (24.3%) 43 (24.9%)
 Other government/unknown 25 (4.0%) 6 (3.5%)
Year of diagnosis .263
 2010 222 (35.3%) 54 (31.2%)
 2011 191 (30.4%) 48 (27.7%)
 2012 216 (34.3%) 71 (41.0%)

EBRT, external beam radiation therapy; GTR, gross total resection; HF-SRS, hypofractionated stereotactic radiation surgery; NOS, not otherwise specified; SRS, stereotactic radiation surgery; STR, subtotal resection; WHO, World Health Organization.